Trial Profile
Phase I-II Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Oct 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Cholangiocarcinoma; Colorectal cancer; Gallbladder cancer; Gastric cancer; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CORGI
- 25 Nov 2009 New trial record